NCT03629054View on ClinicalTrials.gov

This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 27, 2018

Primary Completion Date

November 5, 2018

Study Completion Date

November 5, 2018

Conditions
Healthy
Interventions
DRUG

Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)

single dose

DRUG

Empagliflozin

single dose

DRUG

Linagliptin

single dose

DRUG

Metformin HCl

single dose

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY

NCT03629054 - This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills | Biotech Hunter | Biotech Hunter